Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $18.10M | $-16.56M | $-0.95 |
| 2024 | $28.17M | $-22.09M | $-1.92 |
| 2023 | $37.16M | $-28.75M | $-4.14 |
| 2022 | $24.34M | $-26.47M | $-5.23 |
| 2021 | $14.23M | $-15.98M | $-3.15 |
Social Signal Score
Earnings
Wed, Nov 11(in 3 months)
Typical surprise -127.8% (median, so one quarter with a near-zero estimate can't distort it)
- Fri, May 15$-0.13 vs $-0.10miss
- Wed, Mar 25$-0.26 vs $-0.10miss
- Wed, Nov 12$-0.20 vs $-0.09miss
- Wed, Aug 13$-0.28 vs $-0.09miss
- Wed, May 14$-0.21 vs $-0.09miss
- Wed, Mar 26$-0.14 vs $-0.23beat
Estimates and results for MRAI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
MRAIhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (1)
- Newsprnewswire.com·1d ago·Neutral
… debt restructuring and subsequent financing strengthen capital structure TAMPA, Fla., Aug. 13, 2026 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (OTCQX: MRAI), a leader in innovative healthcare technology, Third-Party Administration (TPA), and Pharmacy Benefit Management ("PBM") services, announced its financial and operational results for the three and six months ended June 30, 2026.
View source ↗